1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Akke, M.
Forsen, S.
Chazin, W.J.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
252
102
121
10.1006/jmbi.1995.0478
7666423
Solution structure of (Cd2+)1-calbindin D9k reveals details of the stepwise structural changes along the Apo-->(Ca2+)II1-->(Ca2+)I,II2 binding pathway.
1995
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
249
441
Determination of the Solution Structure of Apo Calbindin D9K by NMR Spectroscopy
1995
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
231
711
High-Resolution Solution Structure of Calcium-Loaded Calbindin D9K
1993
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
220
173
Molecular Basis for Co-Operativity in Ca2+ Binding in Calbindin D9K. 1H Nuclear Magnetic Resonance Studies of (Cd2+)1-Bovine Calbindin D9K
1991
10.2210/pdb1cdn/pdb
pdb_00001cdn
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
BOVINE MINOR A FORM, CADMIUM-HALF-SATURATED, CADMIUM ION IS BOUND IN C-TERMINAL SITE
8601.688
CALBINDIN D9K
INS(MET 1), P43G
1
man
polymer
INTESTINAL CALCIUM-BINDING PROTEIN, ICBP, ICABP, CABP9K, S100D
no
no
MKSPEELKGIFEKYAAKEGDPNQLSKEELKLLLQTEFPSLLKGGSTLDELFEELDKNGDGEVSFEEFQVLVKKISQ
MKSPEELKGIFEKYAAKEGDPNQLSKEELKLLLQTEFPSLLKGGSTLDELFEELDKNGDGEVSFEEFQVLVKKISQ
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
cattle
Bos
Escherichia
sample
ICABP
9913
Bos taurus
ICABP
562
Escherichia coli
PICB1
database_2
pdbx_database_status
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
Other
1
0
1995-11-14
1
1
2008-03-03
1
2
2011-07-13
1
3
2021-11-03
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
_pdbx_nmr_software.name
_struct_ref_seq_dif.details
Y
BNL
1995-08-04
REL
REL
24
HAVEL,WUTHRICH
refinement
DISGEO
PEARLMAN,CASE,CALDWELL,SEIBEL,SINGH,WEINER,KOLLMAN
refinement
Amber
4.0
n
1
0
A
LYS
1
n
2
LYS
1
A
SER
2
n
3
SER
2
A
PRO
3
n
4
PRO
3
A
GLU
4
n
5
GLU
4
A
GLU
5
n
6
GLU
5
A
LEU
6
n
7
LEU
6
A
LYS
7
n
8
LYS
7
A
GLY
8
n
9
GLY
8
A
ILE
9
n
10
ILE
9
A
PHE
10
n
11
PHE
10
A
GLU
11
n
12
GLU
11
A
LYS
12
n
13
LYS
12
A
TYR
13
n
14
TYR
13
A
ALA
14
n
15
ALA
14
A
ALA
15
n
16
ALA
15
A
LYS
16
n
17
LYS
16
A
GLU
17
n
18
GLU
17
A
GLY
18
n
19
GLY
18
A
ASP
19
n
20
ASP
19
A
PRO
20
n
21
PRO
20
A
ASN
21
n
22
ASN
21
A
GLN
22
n
23
GLN
22
A
LEU
23
n
24
LEU
23
A
SER
24
n
25
SER
24
A
LYS
25
n
26
LYS
25
A
GLU
26
n
27
GLU
26
A
GLU
27
n
28
GLU
27
A
LEU
28
n
29
LEU
28
A
LYS
29
n
30
LYS
29
A
LEU
30
n
31
LEU
30
A
LEU
31
n
32
LEU
31
A
LEU
32
n
33
LEU
32
A
GLN
33
n
34
GLN
33
A
THR
34
n
35
THR
34
A
GLU
35
n
36
GLU
35
A
PHE
36
n
37
PHE
36
A
PRO
37
n
38
PRO
37
A
SER
38
n
39
SER
38
A
LEU
39
n
40
LEU
39
A
LEU
40
n
41
LEU
40
A
LYS
41
n
42
LYS
41
A
GLY
42
n
43
GLY
42
A
GLY
43
n
44
GLY
43
A
SER
44
n
45
SER
44
A
THR
45
n
46
THR
45
A
LEU
46
n
47
LEU
46
A
ASP
47
n
48
ASP
47
A
GLU
48
n
49
GLU
48
A
LEU
49
n
50
LEU
49
A
PHE
50
n
51
PHE
50
A
GLU
51
n
52
GLU
51
A
GLU
52
n
53
GLU
52
A
LEU
53
n
54
LEU
53
A
ASP
54
n
55
ASP
54
A
LYS
55
n
56
LYS
55
A
ASN
56
n
57
ASN
56
A
GLY
57
n
58
GLY
57
A
ASP
58
n
59
ASP
58
A
GLY
59
n
60
GLY
59
A
GLU
60
n
61
GLU
60
A
VAL
61
n
62
VAL
61
A
SER
62
n
63
SER
62
A
PHE
63
n
64
PHE
63
A
GLU
64
n
65
GLU
64
A
GLU
65
n
66
GLU
65
A
PHE
66
n
67
PHE
66
A
GLN
67
n
68
GLN
67
A
VAL
68
n
69
VAL
68
A
LEU
69
n
70
LEU
69
A
VAL
70
n
71
VAL
70
A
LYS
71
n
72
LYS
71
A
LYS
72
n
73
LYS
72
A
ILE
73
n
74
ILE
73
A
SER
74
n
75
SER
74
A
GLN
75
n
76
GLN
75
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
LEU
23
A
N
LEU
24
A
O
VAL
61
A
O
VAL
62
1
A
MET
0
A
MET
1
1
Y
2
A
MET
0
A
MET
1
1
Y
3
A
MET
0
A
MET
1
1
Y
4
A
MET
0
A
MET
1
1
Y
5
A
MET
0
A
MET
1
1
Y
6
A
MET
0
A
MET
1
1
Y
7
A
MET
0
A
MET
1
1
Y
8
A
MET
0
A
MET
1
1
Y
9
A
MET
0
A
MET
1
1
Y
10
A
MET
0
A
MET
1
1
Y
11
A
MET
0
A
MET
1
1
Y
12
A
MET
0
A
MET
1
1
Y
13
A
MET
0
A
MET
1
1
Y
14
A
MET
0
A
MET
1
1
Y
15
A
MET
0
A
MET
1
1
Y
16
A
MET
0
A
MET
1
1
Y
17
A
MET
0
A
MET
1
1
Y
18
A
MET
0
A
MET
1
1
Y
19
A
MET
0
A
MET
1
1
Y
20
A
MET
0
A
MET
1
1
Y
21
A
MET
0
A
MET
1
1
Y
22
A
MET
0
A
MET
1
1
Y
23
A
MET
0
A
MET
1
1
Y
24
A
MET
0
A
MET
1
1
Y
8
A
A
O
OXT
LYS
GLN
1
75
1.74
16
A
A
O
OXT
LYS
GLN
71
75
2.01
18
A
A
O
OXT
LYS
GLN
71
75
1.78
19
A
A
O
OXT
LYS
GLN
1
75
1.70
20
A
A
O
OXT
LYS
GLN
71
75
2.00
24
A
A
O
OXT
LYS
GLN
1
75
2.18
3
A
PHE
50
0.091
SIDE CHAIN
4
A
PHE
36
0.087
SIDE CHAIN
5
A
PHE
50
0.079
SIDE CHAIN
6
A
PHE
50
0.093
SIDE CHAIN
8
A
PHE
50
0.112
SIDE CHAIN
9
A
TYR
13
0.082
SIDE CHAIN
9
A
PHE
50
0.097
SIDE CHAIN
10
A
PHE
50
0.093
SIDE CHAIN
11
A
PHE
50
0.099
SIDE CHAIN
12
A
PHE
50
0.111
SIDE CHAIN
13
A
TYR
13
0.074
SIDE CHAIN
15
A
PHE
50
0.092
SIDE CHAIN
16
A
TYR
13
0.096
SIDE CHAIN
16
A
PHE
50
0.092
SIDE CHAIN
17
A
PHE
36
0.105
SIDE CHAIN
17
A
PHE
50
0.080
SIDE CHAIN
18
A
PHE
50
0.092
SIDE CHAIN
19
A
PHE
50
0.104
SIDE CHAIN
20
A
TYR
13
0.115
SIDE CHAIN
20
A
PHE
50
0.089
SIDE CHAIN
21
A
PHE
50
0.105
SIDE CHAIN
22
A
TYR
13
0.082
SIDE CHAIN
23
A
TYR
13
0.066
SIDE CHAIN
23
A
PHE
50
0.095
SIDE CHAIN
24
A
PHE
50
0.086
SIDE CHAIN
3
A
SER
74
64.06
-39.93
4
A
GLU
17
78.57
-46.20
4
A
SER
74
-178.18
-70.91
5
A
SER
44
34.07
-93.12
5
A
ASP
58
-139.81
-45.50
5
A
SER
74
-159.61
-54.32
6
A
GLU
17
60.74
116.24
6
A
LYS
41
20.83
-88.18
6
A
SER
44
52.25
-136.08
6
A
SER
74
73.14
-62.31
7
A
SER
74
-168.54
73.42
8
A
LYS
16
-61.32
91.27
8
A
GLU
17
77.53
-41.49
8
A
LEU
40
51.20
-73.76
8
A
LYS
55
-65.08
89.60
8
A
ASP
58
-137.01
-42.51
9
A
GLU
17
-154.62
-47.48
9
A
SER
44
-26.54
-59.49
9
A
ASN
56
28.92
48.81
10
A
SER
44
55.10
-146.59
11
A
LYS
41
-114.94
-151.63
11
A
SER
44
52.22
-102.46
11
A
ASN
56
39.85
38.28
11
A
SER
74
45.27
-94.60
12
A
LYS
16
-79.10
44.90
12
A
GLU
17
-170.72
-51.17
12
A
SER
44
35.51
-111.22
12
A
ASN
56
37.91
41.19
13
A
GLU
17
-139.94
-42.44
13
A
ASP
54
-67.41
72.83
13
A
LYS
55
-57.30
99.77
13
A
ASN
56
95.75
5.32
13
A
SER
74
-160.76
57.05
14
A
GLU
17
-155.29
-45.76
14
A
SER
74
-173.85
-47.82
15
A
PHE
36
-145.34
56.91
15
A
ASN
56
-154.28
32.12
16
A
GLU
17
73.20
-37.21
16
A
SER
44
57.00
-162.21
16
A
ASP
54
-116.42
73.89
16
A
ASN
56
-148.20
32.32
16
A
ASP
58
-145.92
-18.79
16
A
SER
74
-77.71
47.25
17
A
GLU
17
54.85
109.71
17
A
SER
44
55.78
-105.00
17
A
SER
74
71.21
-63.76
18
A
SER
44
-96.69
-89.57
18
A
SER
74
-76.74
47.20
19
A
GLU
17
-141.93
-43.49
19
A
ASN
56
37.28
35.71
19
A
SER
74
68.87
-51.43
20
A
LYS
41
-107.62
-65.81
21
A
SER
44
-171.09
-160.53
21
A
ASN
56
-167.17
-47.85
22
A
GLU
17
68.87
-60.43
22
A
LYS
41
-105.77
-68.76
22
A
ASN
56
129.70
-25.26
23
A
ASN
56
-172.28
-37.65
24
A
GLU
17
120.20
-56.65
24
A
ASP
19
58.10
150.95
24
A
LYS
41
26.36
-93.76
24
A
SER
74
57.72
-84.71
Solution structure of (CD2+)1-calbindin D9K reveals details of the stepwise structural changes along the apo--> (CA2+)II1--> (CA2+)I,II2 binding pathway
1
Y
N
A
PRO
3
A
PRO
4
HELX_P
A
GLU
17
A
GLU
18
1
1
15
A
LYS
25
A
LYS
26
HELX_P
A
GLU
35
A
GLU
36
1
2
11
A
LEU
46
A
LEU
47
HELX_P
A
LEU
53
A
LEU
54
1
3
8
A
PHE
63
A
PHE
64
HELX_P
A
ILE
73
A
ILE
74
1
4
11
CALCIUM-BINDING PROTEIN
EF-HAND, CALCIUM-BINDING PROTEIN
S100G_BOVIN
UNP
1
1
P02633
SAKKSPEELKGIFEKYAAKEGDPNQLSKEELKLLLQTEFPSLLKGPSTLDELFEELDKNGDGEVSFEEFQVLVKKISQ
4
78
1CDN
1
75
P02633
A
1
2
76
1
PRO
engineered mutation
GLY
43
1CDN
A
P02633
UNP
46
44
2
anti-parallel
A
GLN
22
A
GLN
23
A
LEU
23
A
LEU
24
A
VAL
61
A
VAL
62
A
SER
62
A
SER
63
Unknown
14
Unknown
12
A
ALA
14
A
ALA
15
14
1_555
A
ALA
15
A
ALA
16
14
1_555
A
LYS
16
A
LYS
17
14
1_555
A
GLU
17
A
GLU
18
14
1_555
A
GLY
18
A
GLY
19
14
1_555
A
ASP
19
A
ASP
20
14
1_555
A
PRO
20
A
PRO
21
14
1_555
A
ASN
21
A
ASN
22
14
1_555
A
GLN
22
A
GLN
23
14
1_555
A
LEU
23
A
LEU
24
14
1_555
A
SER
24
A
SER
25
14
1_555
A
LYS
25
A
LYS
26
14
1_555
A
GLU
26
A
GLU
27
14
1_555
A
GLU
27
A
GLU
28
14
1_555
A
ASP
54
A
ASP
55
12
1_555
A
LYS
55
A
LYS
56
12
1_555
A
ASN
56
A
ASN
57
12
1_555
A
GLY
57
A
GLY
58
12
1_555
A
ASP
58
A
ASP
59
12
1_555
A
GLY
59
A
GLY
60
12
1_555
A
GLU
60
A
GLU
61
12
1_555
A
VAL
61
A
VAL
62
12
1_555
A
SER
62
A
SER
63
12
1_555
A
PHE
63
A
PHE
64
12
1_555
A
GLU
64
A
GLU
65
12
1_555
A
GLU
65
A
GLU
66
12
1_555
1
P 1